|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/215 | |||
| A61K 45/06 | |||
| A61P 31/14 | |||
| A61P 31/16 |
| (11) | Number of the document | 3345605 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17196354.9 |
| Date of filing the European patent application | 2011-10-14 | |
| (97) | Date of publication of the European application | 2018-07-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 393522 P | 2010-10-15 | US | |
| 201161492054 P | 2011-06-01 | US |
| (72) |
BANTIA, Shanta, US
KOTIAN, Pravin, L, US
BABU, Yarlagadda, S, US
|
| (73) |
BioCryst Pharmaceuticals, Inc.,
4505 Emperor Blvd., Durham, NC 27703,
US
|
| (54) | PYRROLOPYRIMIDINE DERIVATIVES FOR USE IN THE INHIBITION OF POLYMERASE |
| PYRROLOPYRIMIDINE DERIVATIVES FOR USE IN THE INHIBITION OF POLYMERASE |